Bharat Biotech International Limited (BBIL) is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella. The company has a strong focus on research and development and has made significant contributions to the field of vaccines and biotherapeutics. BBILs state-of-the-art manufacturing facility is located in Hyderabad, India and is known for its cutting-edge technology and high production capacity. The companys portfolio of products includes vaccines for diseases such as rabies, Japanese encephalitis, cholera, and rotavirus. Additionally, BBIL is also involved in the development of vaccines for COVID-19, and has collaborated with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) to develop Covaxin, a vaccine for the prevention of COVID-19.